Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.40
+0.60 (4.35%)
Aug 21, 2025, 4:00 PM - Market closed

Crescent Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024
Period Ending
Aug '25 Dec '24
Debt / Equity Ratio
-3.26-3.26
Quick Ratio
3.623.62
Current Ratio
3.623.62
Updated Jun 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q